Bryostatin-1: Phase IIa ongoing

Neurotrope dosed the last patient in a double-blind, placebo-controlled, U.S. Phase IIa trial evaluating a single dose of 25 µg/m 2 IV Bryostatin-1 in about 15 patients. ...